Nu Skin Enterprises, Inc.
NUS- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001021561
No open-market purchases or sales by Nu Skin Enterprises, Inc. insiders were filed in the last 90 days; 162 institutions reported holding it in 13F filings for Q2 2026, worth $202.3M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −12 vs. previous quarter
- 162
- 13F valueReported value at the end of Q2 2026
- $202.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NUS, Q2 2026
No superinvestor reported holding NUS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Nu Skin Enterprises, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Winett James MDirector | SSaleClass A Common Stock | −7.20K | $5.62 | −$40.5K | −16.1%37.4K after | 10b5-1 |
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Woodbury Edwina DDirector | SSaleClass A Common Stock | −7.20K | $5.70 | −$41.1K | −10.3%62.4K after | 10b5-1 |
| May 12, 2026 (view filing) | May 11 | 1 day | Nathanson LauraDirector | SSaleClass A Common Stock | −2.68K | $6.73 | −$18.0K | −8.1%30.5K after | |
| Nov 12, 2025 (view filing) | Nov 11 | 1 day | Hatchett Steven KeithChief Product Officer | PPurchaseClass A Common Stock | +5.50K | $9.61 | +$52.9K | +3.4%167.6K after | |
| Sep 4, 2025 (view filing) | Sep 4 | Same day | Nathanson LauraDirector | SSaleClass A Common Stock | −6.49K | $12.22 | −$79.3K | −16.4%33.1K after | |
| Sep 4, 2025 (view filing) | Sep 3 | 1 day | Clark Chayce DavidEVP and General Counsel | SSaleClass A Common Stock | −20.0K | $11.97 | −$239.4K | −7.9%233.1K after | |
| Aug 29, 2025 (view filing) | Aug 29 | Same day | Campbell Daniel WDirector | SSaleClass A Common Stock | −9.05K | $12.12 | −$109.6K | −18.7%39.2K after | |
| Aug 29, 2025 (view filing) | Aug 29 | Same day | Campbell Daniel WDirector | SSaleClass A Common Stock | −23.4K | $12.10 | −$283.0K | −30.5%53.4K after | |
| Jun 3, 2025 (view filing) | Jun 2 | 1 day | Woodbury Edwina DDirector | SSaleClass A Common Stock | −4.53K | $8.44 | −$38.3K | −9.5%42.9K after | 10b5-1 |
| Jun 3, 2025 (view filing) | Jun 2 | 1 day | Battle Emma S.Director | SSaleClass A Common Stock | −4.53K | $8.44 | −$38.3K | −12.8%31.0K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Nu Skin Enterprises, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,315,878 | $22.8M | 0.00% | +24,615+0.6% | Added |
| American Century Companies Inc | 2,301,308 | $12.2M | 0.01% | +280,106+13.9% | Added |
| Coppell Advisory Solutions LLC | 235 | $11.3M | 0.93% | +235 | New |
| Vanguard Capital Management LLC | 2,049,641 | $10.8M | 0.00% | −13,709−0.7% | Reduced |
| Acadian Asset Management LLC | 1,953,174 | $10.3M | 0.01% | +189,519+10.7% | Added |
| Dimensional Fund Advisors LP | 1,796,745 | $9.49M | 0.00% | +61,563+3.5% | Added |
| Prescott Group Capital Management, L.L.C. | 1,794,608 | $9.48M | 0.82% | 00.0% | Unchanged |
| Vanguard Portfolio Management LLC | 1,736,856 | $9.17M | 0.00% | +27,303+1.6% | Added |
| Renaissance Technologies LLC | 1,607,692 | $8.49M | 0.01% | −92,804−5.5% | Reduced |
| Charles Schwab Investment Management Inc | 1,452,937 | $7.67M | 0.00% | −690,357−32.2% | Reduced |